a. What happens when a drug induces an immune response in the patient? How
can it be identified?
Why can't erythropoietin (EPO) drug be produced in E. coli?
c. Can we determine the "wild-type" structure (i.e. the active form in the human
body) of a protein-based molecule from just the primary structure of the protein?
Why or why not?